Fibroadenoma screening: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[screening]] for fibroadenoma. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for fibroadenoma. | There is insufficient evidence to recommend routine [[screening]] for fibroadenoma. | ||
==References== | ==References== | ||
Revision as of 14:33, 16 October 2019
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma screening On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma screening |
|
Risk calculators and risk factors for Fibroadenoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma.
Screening
There is insufficient evidence to recommend routine screening for fibroadenoma.